0001753926-24-001129.txt : 20240618
0001753926-24-001129.hdr.sgml : 20240618
20240618200139
ACCESSION NUMBER: 0001753926-24-001129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Francis Knuettel II
CENTRAL INDEX KEY: 0001433316
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41964
FILM NUMBER: 241053671
MAIL ADDRESS:
STREET 1: 205 NEWBURY ST
STREET 2: SUITE 204
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chromocell Therapeutics Corp
CENTRAL INDEX KEY: 0001919246
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863335449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
BUSINESS PHONE: 9176446313
MAIL ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
4
1
ownership.xml
X0508
4
2024-06-14
0
0001919246
Chromocell Therapeutics Corp
CHRO
0001433316
Francis Knuettel II
C/O CHROMOCELL THERAPEUTICS CORPORATION
4400 ROUTE 9 SOUTH, SUITE 1000
FREEHOLD
NJ
07728
0
1
0
0
CEO, Pres., CFO Treas & Secty
0
Stock Options
1.30
2024-06-14
4
A
0
27778
A
2024-06-14
2034-06-14
Common Stock
27778
52778
I
Camden Capital LLC
Stock Options
1.30
2024-06-14
4
A
0
324000
A
2034-06-14
Common Stock
324000
376778
D
On June 14, 2024, Camden Capital LLC was granted stock options to purchase 27,778 shares of common stock at an exercise price of $1.30 per share, which were fully vested.
The securities are held by Camden Capital LLC. The Reporting Person, as the manager of Camden Capital LLC, is deemed to be a beneficial owner of these securities.
On June 14, 2024, the Reporting Person was granted stock options to purchase 324,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.
/s/ Francis Knuettel II
2024-06-18